Bottom line
Is MCVAX a good fund? The bottom line
MCVAX is a share class of Transamerica Mid Cap Value Opportunities, a managed mid-cap mutual fund from Transamerica.
Annual fees run 1.18% — about $118 a year on every $10,000 invested, more expensive than 75% of mid-cap funds we track.
It returned +3.5% over one year, +7.2% a year over five years, +7.8% a year over ten (as of Dec 31, 2025, per its prospectus).
With $775 million in net assets and 70 holdings, its largest position is Kraft Heinz Co/The (2.6%) and the top 10 make up 22.8% of the portfolio.
This share class carries a front-end sales charge of up to 5.5%; a no-load class or ETF alternative can avoid it.
What to watch
- Expensive for its category (1.18%)
- Front-end sales load up to 5.5%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What MCVAX invests in
Seeks to provide investors with long term capital growth.
Under normal circumstances, the fund invests at least 80% of its net assets (plus the amount of borrowings, if any, for investment purposes) in equity securities of mid cap companies. The fund's sub-adviser, Thompson, Siegel & Walmsley LLC (the sub-adviser), considers mid cap companies to be those companies, at the time of purchase, with market capitalizations within the range of companies included in the Russell Midcap Value Index 1 , a benchmark of the fund, (between approximately $7 billion and $ 59 billion as of June 30, 2025, the date of the last reconstitution). The size of the companies in the Russell Midcap Value Index will change with market conditions. The fund invests primarily in common stocks. The fund may invest in other equity and non-equity securities, including preferred stocks, convertible securities and foreign securities which may take the form of depositary…
From the fund's prospectus (filed Feb 27, 2026).
MCVAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MCVAX | +3.5% | +7.2% | +7.8% |
| Mid-Cap median | +7.9% | +8.1% | +9.9% |
Source: Fund prospectus, as of Dec 31, 2025
What MCVAX costs
On a $10,000 investment, MCVAX's 1.18% expense ratio costs about $118 a year. The prospectus estimates $1,903 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.
MCVAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Kraft Heinz Co/The | 2.57% |
| 2 | Charter Communications Inc | 2.49% |
| 3 | Cognizant Technology Solutions Corp | 2.39% |
| 4 | Occidental Petroleum Corp | 2.34% |
| 5 | Fiserv Inc | 2.28% |
| 6 | Crown Castle Inc | 2.28% |
| 7 | Zimmer Biomet Holdings Inc | 2.17% |
| 8 | Expand Energy Corp | 2.15% |
| 9 | Zoetis Inc | 2.09% |
| 10 | Evergy Inc | 2.08% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 22.8% of the fund. See all top 25 holdings and asset mix →